Last updated: May 29, 2026

Application No. 18/410,391

Oral Care Compositions Comprising Metal Ions

Non-Final OA

Filed

Jan 11, 2024

Priority

May 14, 2018 — provisional 62/671,083 +5 more

Examiner

ROBERTS, LEZAH

Art Unit

1612

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

The Procter & Gamble Company

OA Round

3 (Non-Final)

Interview Optional

— +36.3% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 49% grant rate with +36.3% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 756 resolved cases, 2023–2026

Examiner Intelligence

ROBERTS, LEZAH View full profile →

Grants 49% of resolved cases

Career Allowance Rate

368 granted / 756 resolved

-11.3% vs TC avg

Strong +36% interview lift

Without

With

+36.3%

Interview Lift

resolved cases with interview

Typical timeline

4y 2m

Avg Prosecution

59 currently pending

Career history

832

Total Applications

across all art units

Statute-Specific Performance

§101

0.1%

-39.9% vs TC avg

§103

77.8%

+37.8% vs TC avg

§102

3.9%

-36.1% vs TC avg

§112

2.1%

-37.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 756 resolved cases

Prosecution Timeline

Show 2 earlier events

Jun 04, 2025

Non-Final Rejection mailed

Oct 06, 2025

Response Filed

Jan 28, 2026

Final Rejection mailed

Mar 23, 2026

Applicant Interview (Telephonic)

Mar 24, 2026

Response after Non-Final Action

Apr 28, 2026

Request for Continued Examination

Apr 29, 2026

Response after Non-Final Action

May 06, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/250,411

Patent 12594229

Personal Care Compositions and Methods for the Same

5y 2m to grant Granted Apr 07, 2026

18/462,651

Patent 12594241

TOPIRAMATE ORAL LIQUID SUSPENSION AND USE THEREOF

2y 7m to grant Granted Apr 07, 2026

17/225,146

Patent 12582583

ORAL CARE PRODUCT COMPRISING AN ORAL CARE RHEOLOGICAL SOLID COMPOSITION

4y 11m to grant Granted Mar 24, 2026

18/568,222

Patent 12558387

MULTI-VIRUS ANTI-INFECTIVITY AND PRO-IMMUNITY ASSEMBLY

2y 2m to grant Granted Feb 24, 2026

19/028,294

Patent 12551417

STABILIZED STANNOUS COMPOSITIONS

1y 1m to grant Granted Feb 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

49%

Grant Probability

85%

With Interview (+36.3%)

4y 2m (~1y 9m remaining)

Median Time to Grant

High

PTA Risk

Based on 756 resolved cases by this examiner. Grant probability derived from career allowance rate.